Gastric Floating Controlled Released Tablet of Diuresis Drug : Formulation and In-Vitro Evaluation

The present study focuses on the formulation and evaluation of a gastro-retentive floating controlled release tablet of Amiloride, aimed at enhancing gastric residence time and improving bioavailability. Okra gum and HPMC K4M were used as polymeric matrix formers, Avicel PH 102 as a directly compressible excipient, citric acid to create an acidic microenvironment, and sodium bicarbonate as a gas-generating agent to impart buoyancy. Tablets were prepared by direct compression and evaluated for pre- and post-compression parameters, buoyancy lag time, total floating time, swelling index, in-vitro drug release, and stability. All formulations exhibited acceptable physical characteristics, with floating lag times below 100 seconds and floating durations exceeding 12 hours. The optimized batch (F8) demonstrated a controlled drug release of 95.42% over 12 hours, fitting the Korsmeyer–Peppas and Higuchi release models, indicating anomalous transport. Stability studies confirmed no significant change in physical or release characteristics over three months at 40 °C/75% RH. The developed gastro-retentive system shows potential to reduce dosing frequency, enhance therapeutic efficacy, and minimize side effects associated with Amiloride therapy.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-16
DOI
https://doi.org/10.5281/zenodo.16887070
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gastric Floating Controlled Released Tablet of Diuresis Drug : Formulation and In-Vitro Evaluation

Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

Gastric Floating Controlled Released Tablet of Diuresis Drug : Formulation and In-Vitro Evaluation

article en

Abstract

The present study focuses on the formulation and evaluation of a gastro-retentive floating controlled release tablet of Amiloride, aimed at enhancing gastric residence time and improving bioavailability. Okra gum and HPMC K4M were used as polymeric matrix formers, Avicel PH 102 as a directly compressible excipient, citric acid to create an acidic microenvironment, and sodium bicarbonate as a gas-generating agent to impart buoyancy. Tablets were prepared by direct compression and evaluated for pre- and post-compression parameters, buoyancy lag time, total floating time, swelling index, in-vitro drug release, and stability. All formulations exhibited acceptable physical characteristics, with floating lag times below 100 seconds and floating durations exceeding 12 hours. The optimized batch (F8) demonstrated a controlled drug release of 95.42% over 12 hours, fitting the Korsmeyer–Peppas and Higuchi release models, indicating anomalous transport. Stability studies confirmed no significant change in physical or release characteristics over three months at 40 °C/75% RH. The developed gastro-retentive system shows potential to reduce dosing frequency, enhance therapeutic efficacy, and minimize side effects associated with Amiloride therapy.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 57%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Gastric Floating Controlled Released Tablet of Diuresis Drug : Formulation and In-Vitro Evaluation · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS